Literature DB >> 25534594

Catalytic behaviour in the ring-opening polymerisation of organoaluminiums supported by bulky heteroscorpionate ligands.

Jose A Castro-Osma1, Carlos Alonso-Moreno, Agustín Lara-Sánchez, Antonio Otero, Juan Fernández-Baeza, Luis F Sánchez-Barba, Ana M Rodríguez.   

Abstract

A series of alkyl organoaluminium complexes based on bulky heteroscorpionate ligands were designed as catalysts for the ring-opening polymerisation of cyclic esters. Thus, the treatment of AlX3 (X = Me, Et) with bulky acetamide or thioacetamide heteroscorpionate ligands nbptamH (1) [nbptamH = N-naphthyl-2,2-bis(3,5-dimethylpyrazol-1-yl)thioacetamide], fbpamH (2) [fbpamH = N-fluorenyl-2,2-bis(3,5-dimethylpyrazol-1-yl)acetamide], ptbptamH (3) [ptbptamH = N-phenyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)thioacetamide], ntbptamH (4) [ntbptamH = N-naphthyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)thioacetamide], ptbpamH (5) [ptbpamH = N-phenyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)acetamide] and (S)-mtbpamH (6) [(S)-mtbpamH = (S)-(−)-N-α-methylbenzyl-2,2-bis(3,5-di-tert-butylpyrazol-1-yl)acetamide] for 1 hour at 0 °C afforded the dialkyl aluminium complexes [AlX2{κ(2)-nbptam}] (X = Me 7, Et 8), [AlX2{κ(2)-fbpam}] (X = Me 9, Et 10), [AlX2{κ(2)-ptbptam}] (X = Me 11, Et 12), [AlX2{κ(2)-ntbptam}] (X = Me 13, Et 14), [AlX2{κ2(-)ptbpam}] (X = Me 15, Et 16) and [AlX2{κ(2)-(S)-mtbpam}] (X = Me 17, Et 18). The structures of the complexes were determined by spectroscopic methods and the X-ray crystal structure of 14 was also established. The alkyl-containing aluminium complexes 7–18 can act as efficient single-component initiators for the ring-opening polymerisation of ε-caprolactone and rac-lactide. The polymerisations are living, as evidenced by the narrow polydispersities of the isolated polymers and the linear nature of the number average molecular weight versus conversion plot. Finally, a comparative study of ring-opening polymerisation for new bulky heteroscorpionate aluminium initiators and the less congested aluminium analogues is reported.

Entities:  

Year:  2015        PMID: 25534594     DOI: 10.1039/c4dt03475a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

Review 1.  Polylactide Perspectives in Biomedicine: From Novel Synthesis to the Application Performance.

Authors:  Carmen Moya-Lopez; Joaquín González-Fuentes; Iván Bravo; David Chapron; Patrice Bourson; Carlos Alonso-Moreno; Daniel Hermida-Merino
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

2.  Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer.

Authors:  Enrique Niza; María Del Mar Noblejas-López; Iván Bravo; Cristina Nieto-Jiménez; José Antonio Castro-Osma; Jesús Canales-Vázquez; Agustín Lara-Sanchez; Eva M Galán Moya; Miguel Burgos; Alberto Ocaña; Carlos Alonso-Moreno
Journal:  Nanomaterials (Basel)       Date:  2019-12-16       Impact factor: 5.076

3.  Synthesis of High Molecular Weight Stereo-Di-Block Copolymers Driven by a Co-Initiator Free Catalyst.

Authors:  Carmen Moya-Lopez; Ivan Bravo; José A Castro-Osma; David Chapron; Patrice Bourson; Christelle Vagner; Marianne Cochez; Nils Leoné; Agustín Lara-Sánchez; Carlos Alonso-Moreno; Daniel Hermida-Merino
Journal:  Polymers (Basel)       Date:  2022-01-07       Impact factor: 4.329

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.